SUN PHARMA ADVANCED RESEARCH COMPANY
Back to Income Statement
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|---|
| Operating Income | ₹72 Cr | ₹76 Cr | ₹239 Cr | ₹239 Cr |
What is the latest Revenue of SUN PHARMA ADVANCED RESEARCH COMPANY ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹72 Cr |
| Mar2025 | ₹76 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹239 Cr |
How is Revenue of SUN PHARMA ADVANCED RESEARCH COMPANY Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹72 Cr | -5.00 | |
| Mar2025 | ₹76 Cr | -68.36 | |
| Mar2024 | ₹239 Cr | 0.00 | |
| Mar2023 | ₹239 Cr | - | |
Compare Revenue of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹6,107.1 Cr | -7.4% | -4.8% | 38.5% | Stock Analytics | |
| PRIME FOCUS | ₹24,850.7 Cr | 1.9% | 18.7% | 62.7% | Stock Analytics | |
| SAGILITY | ₹21,360.9 Cr | -0.5% | 8% | 3.6% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹15,264.8 Cr | -2.4% | -5.8% | -40.7% | Stock Analytics | |
| INDEGENE | ₹13,770.0 Cr | -2.9% | 3% | 5% | Stock Analytics | |
| INTERNATIONAL GEMOLOGICAL INSTITUTE | ₹13,528.8 Cr | -1.5% | -9.5% | -9.8% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | -7.4% |
-4.8% |
38.5% |
| SENSEX | -2.8% |
-5.2% |
-8.4% |
You may also like the below Video Courses